CHILDREN'S BENADRYL-D ALLERGY/SINUS LIQUID OTC
Generic Name and Formulations:
Diphenhydramine HCl 12.5mg, phenylephrine HCl 5mg; per 5mL; alcohol- and sugar-free; grape flavor; contains sodium 13mg/5mL.
McNeil Consumer Healthcare
Indications for CHILDREN'S BENADRYL-D ALLERGY/SINUS LIQUID:
Rhinorrhea and congestion.
10mL every 4hrs.
<6yrs: individualize. 6–11yrs: 5mL. Repeat every 4hrs as needed.
During or within 14 days of MAOIs. Concomitant diphenhydramine products (including topicals).
Hypertension. Cardiovascular disease. Asthma. Lower respiratory disorders. Glaucoma. GI or GU obstruction. Diabetes. Thyroid disease. Sodium-restricted diet.
Antihistamine + sympathomimetic.
Hypertensive crisis with MAOIs. β-blockers may increase the pressor effects of sympathomimetics. Alcohol, other CNS depressants potentiated. Guanethidine, other antihypertensives antagonized.
Drowsiness, anticholinergic effects, dizziness, nervousness, insomnia, excitability in children.
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D